Publications by authors named "Suzanne Pierre"

Claim this Profile
S
Safety and Efficacy of Switching SAR341402 Insulin Aspart and Originator Insulin Aspart vs Continuous Use of Originator Insulin Aspart in Adults With Type 1 Diabetes: The GEMELLI X Trial.
Viral N Shah, Amer Al-Karadsheh, Cathy Barnes, Jose Mandry, Samer Nakhle, Suzanne Pierre

J Diabetes Sci Technol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regulatory Issues of Platform Trials: Learnings from EU-PEARL.
Quynh Lan Nguyen, Katharina Hees, Sabina Hernandez Penna, Franz König, Martin Posch, Suzanne Pierre

Clin Pharmacol Ther· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic similarity of switching SAR341402 insulin aspart biosimilar and NovoLog insulin aspart versus continuous use of NovoLog in adults with type 1 diabetes: The GEMELLI X trial.
Viral N Shah, Amer Al-Karadsheh, Cathy Barnes, Jose Mandry, Samer Nakhle, Suzanne Pierre

Diabetes Obes Metab· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy, Safety, and Immunogenicity of Biosimilar Insulin Aspart Premix SAR341402 Mix 70/30 Compared with Originator Insulin Aspart Mix 70/30 in Adults with Diabetes (GEMELLI M): A Subgroup Analysis by Prior Type of Premix Insulin.
S R Aravind, Kiran P Singh, Liliia Mogylnytska, Alsu G Zalevskaya, Beata Matyjaszek-Matuszek, Suzanne Pierre

Diabetes Ther· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biosimilar Insulin Aspart Premix SAR341402 Mix 70/30 Versus Originator Insulin Aspart Mix 70/30 (NovoMix 30) in People with Diabetes: A 26-Week, Randomized, Open-Label Trial (GEMELLI M).
S R Aravind, Kiran P Singh, Grace Aquitania, Liliia Mogylnytska, Alsu G Zalevskaya, Suzanne Pierre

Diabetes Ther· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy, Safety, and Immunogenicity of Insulin Aspart Biosimilar SAR341402 Compared with Originator Insulin Aspart in Adults with Diabetes (GEMELLI 1): A Subgroup Analysis by Prior Type of Mealtime Insulin.
Viral N Shah, Edward Franek, Karin Wernicke-Panten, Suzanne Pierre, Bhaswati Mukherjee

Diabetes Ther· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Tolerability of Insulin Aspart Biosimilar SAR341402 Versus Originator Insulin Aspart (NovoLog) When Used in Insulin Pumps in Adults with Type 1 Diabetes: A Randomized, Open-Label Clinical Trial.
James Thrasher, Sarit Polsky, Lionel Hovsepian, Irene Nowotny, Suzanne Pierre

Diabetes Technol Ther· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mean annual temperature influences local fine root proliferation and arbuscular mycorrhizal colonization in a tropical wet forest.
Suzanne Pierre, Creighton M Litton, Christian P Giardina, Jed P Sparks, Timothy J Fahey

Ecol Evol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety of Insulin Lispro and a Biosimilar Insulin Lispro When Administered Through an Insulin Pump.
James Thrasher, Howard Surks, Irene Nowotny, Suzanne Pierre, Baerbel Rotthaeuser

J Diabetes Sci Technol· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-Insulin Antibodies and Adverse Events with Biosimilar Insulin Lispro Compared with Humalog Insulin Lispro in People with Diabetes.
Philip Home, Karl-Michael Derwahl, Monika Ziemen, Karin Wernicke-Panten, Suzanne Pierre

Diabetes Technol Ther· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Biosimilar SAR342434 Insulin Lispro in Adults with Type 2 Diabetes, Also Using Insulin Glargine: SORELLA 2 Study.
Karl-Michael Derwahl, Timothy S Bailey, Karin Wernicke-Panten, Lin Ping, Suzanne Pierre

Diabetes Technol Ther· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Biosimilar SAR342434 Insulin Lispro in Adults with Type 1 Diabetes Also Using Insulin Glargine-SORELLA 1 Study.
Satish K Garg, Karin Wernicke-Panten, Maria Rojeski, Suzanne Pierre, Yvonne Kirchhein

Diabetes Technol Ther· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis